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1 © European Food Safety Authority, 2011 
SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 59, Revision 1 
(FGE.59Rev1): 
Consideration of aliphatic and aromatic ethers evaluated by JECFA (61st 
meeting and 63rd meeting) structurally related to aliphatic, alicyclic and 
aromatic ethers including anisole derivatives evaluated by EFSA in FGE.23 
Rev2 (2010)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present consideration concerns a group of 30 flavouring substances consisting of aliphatic and 
aromatic ethers evaluated by the JECFA. The substances were evaluated through a stepwise approach 
that integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel agrees with the 
application of the Procedure as performed by the JECFA for the 30 substances considered in this FGE 
and agrees with the JECFA conclusion, “No safety concern at estimated levels of intake as flavouring 
substances” based on the MSDI approach. Besides the safety assessment of these flavouring 
substances, the specifications for the materials of commerce have also been considered and for two 
substances, are information on the composition of stereoisomeric mixture lacking. 
© European Food Safety Authority, 2011 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. 
The present consideration concerns a group of 30 flavouring substances consisting of aliphatic and 
aromatic ethers by the JECFA (61st and 63rd meeting) and will be considered in relation to the EFSA 
evaluation of 19 aliphatic, alicyclic and aromatic ethers including anisole derivatives of evaluated 
in the Flavouring Group Evaluation 23, Revision 2 (FGE.23Rev2).The Panel concluded that all the 
30 substances in the JECFA flavouring group of aliphatic and aromatic ethers are structurally related 
to the group of 19 aliphatic, alicyclic and aromatic ethers including anisole derivatives from chemical 
groups 15, 16, 22, 26 and 30 evaluated by EFSA in the Flavouring Group Evaluation 23, Revision 2 
(FGE.23Rev2).  
The Panel agrees with the application of the Procedure as performed by the JECFA for the 30 
substances considered in this FGE. 
For all 30 substances evaluated through the Procedure use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment to finalise the evaluation.  
In order to determine whether the conclusion for the 30 JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity are available for 28 of the 30 JECFA 
evaluated substances. For two substances [FL-no: 13.037 and 13.072],  have the composition of the 
mixture of diastereoisomers not been specified sufficiently. Thus, for the two substances [FL-no: 
13.037 and 13.072], the Panel has reservations (information on stereoisomeric composition is 
missing).  
For the remaining 28 of the 30 JECFA evaluated aliphatic and aromatic ethers [FL-no: 03.001, 03.003, 
03.004, 03.005, 03.006, 03.007, 03.010, 03.019, 04.014, 04.015, 04.016, 04.032, 04.033, 04.034, 
04.035, 04.038, 04.039, 04.040, 04.043, 04.054, 04.062, 04.063, 04.074, 13.088, 13.094, 13.098, 
13.165 and 16.088] the Panel agrees with the JECFA conclusion “no safety concern at estimated levels 
of intake as flavouring substances” based on the MSDI approach. 
 
KEY WORDS 
Aliphatic and aromatic ethers, JECFA, 61st meeting, aliphatic, alicyclic and aromatic ethers, anisole derivatives, 
chemical groups 15, 16, 26, FGE.59, FGE 23Rev2. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 – 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE 
EFSA is requested to consider the JECFA evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000 (EC, 2000a). These flavouring substances are listed in the Register which was adopted 
by Commission Decision 1999/217 EC (EC, 1999a) and its consecutive amendments. 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
Flavouring Group Evaluation 59, Revision 1 
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meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”)” (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are 
provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Flavouring Group Evaluation 59, Revision 1 
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Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
At its 61st meeting the JECFA evaluated a group of 29 flavouring substances consisting of aliphatic 
and aromatic ethers. These substances have been considered by EFSA in FGE.59 (EFSA, 2008ac).  
FGE Opinion adopted by 
EFSA 
Link No. of candidate 
substances 
59 3 July 2007 http://www.efsa.europa.eu/en/scdocs/scdoc/639.htm 29 
59Rev1 22 March 2011  30 
 
At its 63rd meeting the JECFA evaluated a group of 32 monocyclic and bicyclic secondary alcohols, 
ketones and related esters including one aliphatic ether, l-menthyl methyl ether [FL-no: 16.088]. The 
Panel concluded that this ether should be considered together with the ethers from FGE.59 in FGE.59 
Revision 1 (FGE.59Rev1). This consideration will therefore deal with 30 JECFA evaluated aliphatic 
and aromatic ethers. 
In FGE.59, information on stereoisomerism or composition of mixture of isomers was requested for 
the following substances: [FL no: 03.005, 13.037, 13.072, 13.088, 13.094, 13.098, 13.165, 03.007 
and 03.010]. Industry has submitted additional information on the specifications for these substances, 
which has been taken into consideration in this revision of FGE.59. Sufficiently information was not 
submitted for [FL-no: 13.037 and 13.072]. 
In FGE.59 seven substances [FL-no: 03.010, 04.033, 04.040, 04.062, 04.063, 04.074 and 13.165] 
could not be evaluated using the Procedure, because no EU production figures were available. In 
the course of 2010, Industry provided EU production figures for these seven substances together 
with similar data on approximately 100 other substances from 27 different FGEs. In order to 
avoid unnecessary delay, these substances were evaluated in a special FGE, FGE.96, in which EU 
production volumes / anticipated production volumes submitted on request by DC SANCO have 
been included in the evaluation (EFSA, 2010aj). The EU production volumes of these seven 
substances and the outcome of the evaluations from FGE.96 have also been included in the 
current revision of FGE.59.  
1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
The JECFA has evaluated a group of 29 flavouring substances consisting of aliphatic and aromatic 
ethers (JECFA, 2004b) and one aliphatic ether, l-menthyl methyl ether [FL-no: 16.088], in the group 
of monocyclic and bicyclic alcohols, ketones and related esters (JECFA, 2006d). 
Flavouring Group Evaluation 59, Revision 1 
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1.1.2. EFSA Considerations 
The Panel concluded that these 30 substances are structurally related to the group of 19 aliphatic, 
alicyclic and aromatic ethers including anisole derivatives from chemical groups 15, 16, 22, 26 and 30 
evaluated by EFSA in Flavouring Group Evaluation 23, Revision 2 (FGE.23Rev2). 
1.2. Isomers 
1.2.1. Status 
The following four JECFA-evaluated substances have one chiral centre [FL-no: 03.005, 13.088, 
13.094 and 13.165], two substances have two chiral centres [FL-no: 13.037 and 13.098], one 
substance has three chiral centres [FL-no: 16.088] and one substance has four chiral centres [FL-no: 
13.072]. 
1.2.2. EFSA Considerations 
The steroisomeric composition has been specified for [FL-no: 03.005, 13.088, 13.094, 13.098, 13.165 
and 16.088]. For [FL-no: 13.037 and 13.072], Industry has informed that it occurs as a mixture of 
diastereoisomers (EFFA, 2010a), however, the composition of the mixture has to be specified (see 
Table 1). 
1.3. Specifications 
1.3.1. JECFA Status 
JECFA specifications are available for all 30 substances (JECFA, 2003b; JECFA, 2005b), see Table 1. 
1.3.2. EFSA Considerations 
The available specifications are considered adequate for 28 substances. For two substances [FL-no: 
13.037 and 13.072] information on the composition of stereoisomeric mixture is lacking (see Section 
1.2). 
2. Intake Estimations 
2.1. JECFA Status 
For all 30 substances evaluated through the JECFA Procedure intake data are available for the EU, see 
Table 3.1.  
2.2. EFSA Considerations 
No comments 
Flavouring Group Evaluation 59, Revision 1 
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3. Genotoxicity Data 
3.1. Genotoxicity Studies – Text Taken4 from the JECFA (JECFA, 2004b) 
No information on [FL-no: 16.088] or other ethers is available from the JECFA evaluation of 32 
monocyclic and bicyclic secondary alcohols, ketones and related esters including one aliphatic ether 
(JECFA, 2006a). 
In vitro 
Negative results were reported in the standard Ames assay when various strains of Salmonella 
typhimurium (TA97, TA98, TA100, TA102, TA1532, TA1535, TA1537, TA1538, TA1978 and 
TA2636) were incubated with eucalyptol [FL-no: 03.001 (1,8-cineole)], anisole [FL-no: 04.032], p-
methylanisole [FL-no: 04.015 (1-Methoxy-4-methylbenzene)], p-propylanisole [FL-no: 04.039 (1-
methoxy-4-propylbenzene)], 1,2-dimethoxybenzene [FL-no: 04.062], m-dimethoxybenzene [FL-no: 
04.016 )1,3-dimethoxybenzene)], p-dimethoxy-benzene [(FL-no: 04.034 (1,4-dimethoxybenzene)], 
diphenyl ether [FL-no: 04.035], dibenzyl ether [FL-no: 03.004], beta-naphthyl methyl ether [FL-no: 
04.074 (2-methoxynaphtalene)], beta-naphthyl ethyl ether [FL-no: 04.033], or beta-naphthyl isobutyl 
ether [FL-no: 04.054 (isobutyl beta- naphthyl ether)] at concentrations of up to 50 000 µg/plate, with 
and without metabolic activation (Clark et al., 1979; Florin et al., 1980; Rapson et al., 1980; Pagano et 
al., 1983; Haworth et al., 1983; Pagano et al., 1988; Wild et al., 1983; Westinghouse Electric 
Corporation, 1984; Heck et al., 1989; Gomes-Carneiro et al., 1998).  
Eucalyptol [FL-no: 03.001] was tested in assays for sister chromatid exchange in Chinese hamster 
ovary cells in vitro (Galloway et al., 1987a; Sasaki et al., 1989). A statistically significant increase (p 
<0.05) in the incidence of sister chromatid exchanges in the absence of metabolic activation was 
reported at high concentrations (200–500 µg/ml) that induced cell cycle delay (Galloway et al., 
1987a). This finding was, however, not confirmed in a subsequent study that also used eucalyptol at 
concentrations that extended into the toxic range (Sasaki et al., 1989), nor was any increased incidence 
of sister chromatid exchange found in the presence of metabolic activation (Galloway et al., 1987a). In 
an assay for sister chromatid exchange in human lymphocytes in vitro, anisole [FL-no: 04.032) did not 
induce sister chromatid exchange at concentrations of up to 2 mmol/l (216 µg/ml) (Jansson et al., 
1988).  
Eucalyptol [FL-no: 03.001] did not induce chromosomal aberrations in Chinese hamster ovary cells at 
concentrations ranging from 479 to 663 µg/ml without metabolic activation, and from 630 to 810 
µg/ml with metabolic activation (Galloway et al., 1987a). Diphenyl ether [FL-no: 04.035], at 
concentrations of 5 to 5000 µg/ml, did not induce chromosomal aberrations in Chinese hamster ovary 
cells with or without metabolic activation (San Sebastian, 1989b).  
In an abstract for a preliminary screening study that was not published, 1-methoxy-4-methylbenzene 
[FL-no: 04.015] was tested in an assay for unscheduled DNA synthesis in vitro using hepatocytes 
isolated from adult male Fischer or Sprague-Dawley rats. Positive responses were reported for p-
methylanisole, but only at cytotoxic concentrations (188 µg/ml; relative survival, 60 –78 %). At lower 
non-cytotoxic concentrations (5–100 µg/ml), there was no evidence of unscheduled DNA synthesis 
(Heck et al., 1989). Furthermore, incubation of the related substance p-propylanisole [FL-no: 04.039] 
with rat hepatocytes showed no evidence of unscheduled DNA synthesis (Howes et al., 1990). 
Diphenyl ether gave negative results in two separate assays for unscheduled DNA synthesis in rat 
hepatocytes in vitro at concentrations ranging from 0.5 to 100 µg/ml (Bakke and Mirsalis, 1987) and 
from 0.1 to 1000 µg/ml (Farr, 1987a).  
                                                     
 
4 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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In an assay for DNA repair in Bacillus subtilis H17 and M45 (rec assay), eucalyptol gave negative 
results at concentrations ranging from 18 to 20 000 mg/disc (Oda et al., 1979; Yoo, 1986). 
In vivo 
In an assay for micronucleus formation in bone marrow cells, male and female NMRI mice received 
single injections of p-propylanisole [FL-no: 04.039] at a dose of 750, 1125, or 1500 mg/kg bw in olive 
oil. The mice were killed 30 h after injection. Results were expressed as mean number of 
micronucleated polychromatic erythrocytes per 1000 polychromated erythrocytes. There was no 
evidence of an increase in the incidence of micronucleated polychromatic erythrocytes at any of the 
concentrations of p-propylanisole tested when compared with the values for controls (Wild et al., 
1983).  
Assays for micronucleus formation were also performed with four other aromatic ethers. There was no 
evidence of an increase in the frequency of micronucleated polychromatic erythrocytes reported when 
male and female NMRI mice were given intraperitoneal injections of m-dimethoxybenzene [FL-no: 
04.016] at up to 1382 mg/kg bw, dibenzyl ether [FL-no: 03.004] at up to 1000 mg/kg bw, beta-
naphthyl ethyl ether [FL-no: 04.033] at up to 861 mg/kg bw, or beta-naphthyl isobutyl ether [FL-no: 
04.054] at up to 2000 mg/kg bw (Wild et al., 1983).  
Assays for sex-linked recessive lethal mutations in Drosophila melanogaster were performed using 5 
mmol/l of p-propylanisole [FL-no: 04.039], 25 mmol/l of m-dimethoxybenzene [FL-no: 04.016], 10 
mmol/l of dibenzyl ether [FL-no: 03.004], 25 mmol/l of beta-naphthyl ethyl ether [FL-no: 04.033], or 
25 mmol/l of beta-naphthyl isobutyl ether [FL-no: 04.054] (Wild et al., 1983). None of these 
substances was reported to give positive results in this assay (Wild et al., 1983).  
In one of four assays with p-propylanisole [FL-no: 04.039], the frequency of sex-linked recessive 
lethal mutations was significantly increased (p <0.01), a result that was not confirmed when the assay 
was repeated three times at the same test concentration (5 mmol/l). For beta-naphthyl isobutyl ether 
[FL-no: 04.054], a slight increase in sex-linked recessive lethal mutations "with a borderline 
significance of p = 0.05" was reported only in the second of three broods analysed, which the authors 
concluded to be of questionable relevance. The "borderline" significance was due to the abnormally 
low frequency of sex-linked recessive lethal mutations in the corresponding control brood for the 
second brood (0.19 %) compared with the values for controls (0.23 % and 0.29 %) for the other two 
broods. 
Conclusion on genotoxicity 
The Committee concluded that there was no confirmed evidence of genotoxicity for any of the 
aliphatic or aromatic ethers used as flavouring agents 
For a summary of in vitro / in vivo genotoxicity data considered by JECFA see Table 2.1. 
3.2. Genotoxicity Studies - Text Taken5 from EFSA FGE.23Rev2 (EFSA, 2010ac) 
In vitro / in vivo 
There are only four genotoxicity studies carried out on the candidate substances 1,2,3-
trimethoxybenzene [FL-no: 04.084] and vanillin 3-(l-menthoxy)propane-1,2-diol acetal [FL-no: 
02.248]. These studies provided negative results but are of limited value. There have been a number of 
studies carried out on the supporting substances and these generally show that there is no cause for 
                                                     
 
5 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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concern regarding their genotoxicity. Two in vitro studies produced positive results; these studies are 
described in greater detail below. None of the in vivo tests showed positive results. 
One of the in vitro genotoxicity studies (Heck et al., 1989) gave a positive result for the supporting 
substance 1-methoxy-4-methylbenzene [FL-no: 04.015] at a concentration of 188 microgram/ml. This 
study was an unscheduled DNA synthesis study. The test was carried out twice, but significant 
differences were seen between the initial results and the repeat assay and there was no explanation 
why these two results may have been different. Therefore, no definite conclusions could be drawn. 
A positive result was seen in a sister chromatid exchange study on the supporting substance 1,8-
cineole [FL-no: 03.001] (Galloway et al., 1987). This study was only positive without S9 activation 
and at levels of 1,8-cineole of 200 and 500 micrograms/ml which induced cell cycle delay and 
therefore were cytotoxic. There are several other genotoxicity tests on this substance, including 
another sister chromatid exchange study (although the concentrations of test substance were much 
lower in this study), that have given negative results. In the light of these results in several 
genotoxicity studies at gene and chromosomal level the positive result in the sister chromatid 
exchange assay by Galloway (Galloway et al., 1987) is considered not to be of relevance for the 
overall evaluation. It is therefore concluded that 1,8-cineole is not genotoxic. 
Conclusion on genotoxicity 
In summary the Panel concluded that the genotoxicity data available do not preclude the evaluation of 
the candidate substances through the Procedure. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA see Table 2.2 and 2.3. 
3.3. EFSA Considerations 
The Panel concluded that the data available do not preclude evaluation of the 30 JECFA evaluated 
aliphatic and aromatic ethers through the Procedure. 
4. Application of the Procedure 
4.1. Application of the Procedure to 30 Aliphatic and Aromatic Ethers by the JECFA 
(JECFA, 2004b; JECFA, 2006a) 
According to the JECFA nine of the substances belong to structural class I, 12 to structural class II and 
nine to structural class III using the decision tree approach presented by Cramer et al. (Cramer et al., 
1978). 
The JECFA concluded 27 aliphatic and aromatic ethers at step A3 in the JECFA Procedure – i.e. the 
substances are expected to be metabolised to innocuous products (step 2) and concluded that the 
intakes for the substances are below the thresholds for their structural classes I, II and III (step A3). 
Three substances [FL-no: 03.001, 03.004 and 04.039] were concluded at step A5 – i.e. the intakes are 
above the thresholds for their structural classes, the substances are not endogenous, but for these three 
substances a NOAEL were found from which adequate margins of safety to the estimated intake of the 
substances [FL-no: 03.001, 03.004 and 04.039] could be calculated. 
In conclusion, the JECFA evaluated all 30 substances as to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the 30 aliphatic and aromatic ethers are summarised in Table 3.1: Summary of 
Safety Evaluation of 30 Aliphatic and Aromatic Ethers (JECFA, 2004b; JECFA, 2006a). 
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4.2. Application of the Procedure to 19 Aliphatic, Alicyclic and Aromatic Ethers Including 
Anisole Derivatives from Chemical Groups 15, 16, 22, 26 and 30 by EFSA (EFSA, 
2010ac) 
Nineteen substances were evaluated in FGE.23Rev2. Two substances are classified into structural 
class I, seven substances into structural class II and 10 substances into structural class III using the 
decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
The 19 substances were all concluded at step A3 – i.e. the substances are expected to be metabolised 
to innocuous products (step 2) and the estimated daily intakes are below the thresholds for the 
structural classes (step A3). 
In conclusion the Panel evaluated all 19 substances as to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The stepwise evaluations of the 19 substances are summarised in Table 3.2: Summary of Safety 
Evaluation Applying the Procedure (EFSA/ FGE.23Rev2). 
4.3. EFSA Considerations 
The Panel agrees with the application of the Procedure as performed by the JECFA for all 30 
substances in the group of aliphatic and aromatic ethers. 
Accordingly, these 30 substances do not pose a safety concern when used at estimated levels of intake 
as flavouring substances, based on the MSDI approach. 
5. Conclusion 
The Panel concluded that all the 30 substances in the JECFA flavouring group of aliphatic and 
aromatic ethers are structurally related to the group of 19 aliphatic, alicyclic and aromatic ethers 
including anisole derivatives from chemical groups 15, 16, 22, 26 and 30 evaluated by EFSA in the 
Flavouring Group Evaluation 23, Revision 2 (FGE.23Rev2).  
The Panel agrees with the application of the Procedure as performed by the JECFA for the 30 
substances considered in this FGE. 
For all 30 substances evaluated through the Procedure use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment to finalise the evaluation.  
In order to determine whether the conclusion for the 30 JECFA evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity are available for 28 of the 30 JECFA 
evaluated substances. For two substances [FL-no: 13.037 and 13.072], have the composition of the 
mixture of diastereoisomers not been specified sufficiently. Thus, for the two substances [FL-no: 
13.037 and 13.072], the Panel has reservations (information on stereoisomeric composition is 
missing). For the remaining 28 of the 30 JECFA evaluated aliphatic and aromatic ethers [FL-no: 
03.001, 03.003, 03.004, 03.005, 03.006, 03.007, 03.010, 03.019, 04.014, 04.015, 04.016, 04.032, 
04.033, 04.034, 04.035, 04.038, 04.039, 04.040, 04.043, 04.054, 04.062, 04.063, 04.074, 13.088, 
13.094, 13.098, 13.165 and 16.088] the Panel agrees with the JECFA conclusion “no safety concern at 
estimated levels of intake as flavouring substances” based on the MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY  
Table 1:Specifications Summary for the JECFA Evaluated Substances in the Present Group (JECFA, 2003b; JECFA, 2005b) 
Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of aliphatic and aromatic ethers (JECFA, 2003b; JECFA, 2005b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
03.001 
1234 
1,8-Cineole 
O
2465 
182 
470-82-6 
Liquid 
C10H18O 
154.25 
Insoluble 
Soluble 
176-177 
 
IR 
98 % 
1.454-1.460 
0.921-0.924 
 
 
03.003 
1252 
Benzyl ethyl ether O
 
2144 
521 
539-30-0 
Liquid 
C9H12O 
136.19 
Insoluble 
Soluble 
186-187 
 
NMR 
98 % 
1.493-1.498 
0.947-0.951 (20°) 
 
 
03.004 
1256 
Dibenzyl ether 
O
 
2371 
11856 
103-50-4 
Liquid 
C14H14O 
198.27 
Insoluble 
Soluble 
295-298 
 
IR 
99 % 
1.558-1.563 
1.040-1.045 
 
 
03.005 
1231 
2-Butyl ethyl ether O
 
3131 
10911 
2679-87-0 
Liquid 
C6H14O 
102.18 
Insoluble 
Soluble 
81 
 
NMR 
99 % 
1.378-1.383 
0.748-0.753 (20°) 
Racemate (EFFA, 2010a) 
03.006 
1254 
2-Methoxyethyl benzene O
 
3198 
11812 
3558-60-9 
Liquid 
C9H12O 
136.19 
Insoluble 
Soluble 
185-187 
 
NMR 
99 % 
1.497-1.501 
0.945-0.951 
 
 
03.007 
1233 
1,4-Cineole 
O
 
3658 
11225 
470-67-7 
Liquid 
C10H18O 
154.25 
Insoluble 
Soluble 
172-174 
 
NMR 
75 % 
1.449-1.456 
0.898-0.902 
1,4-Cineole (75%), 
secondary component 1,8-
cineole (20-25%) (EFFA, 
2010a) 
 
03.010 
1253 
Benzyl butyl ether O
 
2139 
520 
588-67-0 
Liquid 
C11H16O 
164.25 
Insoluble 
Soluble 
220-221 
 
NMR 
92.6 % 
1.480-1.485 
0.928-0.933 (10°) 
Minimum assay value is 
(92.6%), secondary 
component Benzyl alcohol 
(2-5%) (EFFA, 2010a) 
 
03.019 
1232 
Prenyl ethyl ether O
 
3777 
 
22094-00-4 
Liquid 
C7H14O 
114.19 
Insoluble 
Soluble 
64-66 (208 hPa) 
 
IR NMR MS 
99.4 % 
1.416-1.422 
0.797-0.802 
 
 
04.014 
1242 
1-Methoxy-2-methylbenzene O
 
2680 
187 
578-58-5 
Liquid 
C8H10O 
122.17 
Insoluble 
Soluble 
172 
- 
NMR 
99 % 
1.518-1.522 
(15.3°) 
0.983-0.986 
(15.5°) 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of aliphatic and aromatic ethers (JECFA, 2003b; JECFA, 2005b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
04.015 
1243 
1-Methoxy-4-methylbenzene O
 
2681 
188 
104-93-8 
Liquid 
C8H10O 
122.17 
Insoluble 
Soluble 
174 
- 
IR 
99 % 
1.510-1.513 
0.996-1.004 
 
 
04.016 
1249 
1,3-Dimethoxybenzene OO
 
2385 
189 
151-10-0 
Liquid 
C8H10O2 
138.17 
Slightly soluble 
Soluble 
215-217.5 
- 
NMR 
97 % 
1.521-1.527 
1.053-1.057 
 
 
04.032 
1241 
Anisole O
 
2097 
2056 
100-66-3 
Liquid 
C7H8O 
108.14 
Insoluble 
Soluble 
154 
- 
IR 
99 % 
1.515-1.518 
0.990-0.993 
 
 
04.033 
1258 
beta-Naphthyl ethyl ether O
 
2768 
2058 
93-18-5 
Solid 
C12H12O 
172.23 
Insoluble 
Soluble 
n.a. 
37 
NMR 
99 % 
n.a. 
n.a. 
 
 
04.034 
1250 
1,4-Dimethoxybenzene O
O  
2386 
2059 
150-78-7 
Solid 
C8H10O2 
138.17 
Slightly soluble 
Soluble 
n.a. 
56-60 
NMR 
98 % 
n.a. 
n.a. 
 
 
04.035 
1255 
Diphenyl ether 
O  
3667 
2201 
101-84-8 
Solid 
C12H10O 
170.21 
Insoluble 
Soluble 
259 
26.8 
NMR 
99 % 
1.578-1.583 
1.071-1.075 
 
 
04.038 
1247 
Carvacryl ethyl ether 
O
2246 
11840 
4732-13-2 
Liquid 
C12H18O 
178.28 
Slightly soluble 
Soluble 
235 
- 
NMR 
95 % 
1.502-1.509 
0.935-0.942 
 
 
04.039 
1244 
1-Methoxy-4-propylbenzene O
 
2930 
11835 
104-45-0 
Liquid 
C10H14O 
150.22 
Slightly soluble 
Soluble 
212-213 
- 
IR 
99 % 
1.503-1.506 
0.940-0.943 
 
 
04.040 
1251 
1,2-Dimethoxy-4-vinylbenzene O
O  
3138 
11228 
6380-23-0 
Liquid 
C10H12O2 
164.20 
Slightly soluble 
Soluble 
203-205 (26hPa) 
- 
NMR 
99 % 
1.520-1.526 
1.006-1.012 
 
 
04.043 
1246 
1-Isopropyl-2-methoxy-4-methylbenzene 
O
3436 
11245 
1076-56-8 
Liquid 
C11H16O 
164.25 
Insoluble 
Soluble 
216 
- 
NMR 
98 % 
1.504-1.508 
0.936-0.940 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of aliphatic and aromatic ethers (JECFA, 2003b; JECFA, 2005b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
04.054 
1259 
Isobutyl beta-naphthyl ether 
O
3719 
11886 
2173-57-1 
Solid 
C14H16O 
200.28 
Insoluble 
Soluble 
n.a. 
33 
NMR 
98 % 
n.a. 
n.a. 
 
 
04.062 
1248 
1,2-Dimethoxybenzene O
O  
3799 
10320 
91-16-7 
Liquid 
C8H10O2 
138.17 
Insoluble 
Soluble 
206-207 
 
IR NMR 
98 % 
1.533-1.536 
1.082-1.086 
 
 
04.063 
1245 
1,3-Dimethyl-4-methoxybenzene 
O
3828 
- 
6738-23-4 
Liquid 
C9H12O 
136.20 
Slightly soluble 
Soluble 
193 
- 
IR NMR MS 
96.5 % 
1.512-1.516 
0.963-0.967 
 
 
04.074 
1257 
2-Methoxynaphthalene O
 
- 
- 
93-04-9 
Solid 
C11H10O 
158.20 
Insoluble 
Soluble 
n.a. 
73-75 
NMR 
99 % 
n.a. 
n.a. 
 
 
13.037 
1237 
2-(2-Methylprop-1-enyl)-4-
methyltetrahydropyran 
O 3236 
2269 
16409-43-1 
Liquid 
C10H18O 
154.25 
Slightly soluble 
Soluble 
182 
- 
NMR 
99 % 
1.453-1.457 
0.873-0.877 
Mixture of diastereoisomers 
(EFFA, 2010a). 
13.072 
1240 
1,5,5,9-Tetramethyl-13-oxatricyclo 
[8.3.0.0.(4.9)]tridecane O
3471 
10514 
3738-00-9 
Solid 
C16H28O 
236.40 
Insoluble 
Soluble 
n.a. 
75-85 
NMR 
96 % 
n.a. 
n.a. 
Mixture of diastereoisomers 
(EFFA, 2010a). 
13.088 
1235 
3,6-Dihydro-4-methyl-2-(2-methylprop-1-
en-1-yl)-2H-pyran 
O 3661 
- 
1786-08-9 
Liquid 
C10H16O 
152.24 
Insoluble 
Soluble 
68-72 (9 hPa) 
- 
IR NMR MS 
97 % 
1.472-1.478 
0.900-0.908 
Racemate (EFFA, 2010a). 
13.094 
1236 
2,6,6-Trimethyl-2-vinyltetrahydropyran O
 
3735 
10976 
7392-19-0 
Liquid 
C10H18O 
154.25 
Insoluble 
Soluble 
22 (3 hPa) 
- 
NMR 
99 % 
1.446-1.452 
0.866-0.871 
Racemate (EFFA, 2010a). 
13.098 
1238 
Theaspirane 
O
 
3774 
10515 
36431-72-8 
Liquid 
C13H22O 
194.32 
Insoluble 
Soluble 
65 (1 hPa) 
- 
IR NMR MS 
97 % 
1.487-1.490 
0.938-0.943 
Racemate, and mixture of 
(Z)-isomer (55-58%), (E)-
isomer (42-45%) and 5 other 
secondary components 8-
13.5% (EFFA, 2010a). 
 
13.165 
1239 
6,7,8,8a-Tetrahydro-2,5,5,8a-tetramethyl-
5H-1-benzopyran 
O 3822 
- 
5552-30-7 
Liquid 
C13H20O 
192.3 
Insoluble 
Soluble 
240 
- 
IR NMR 
96.7 % 
1.499-1.505 
0.950-0.955 
Racemate (EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of aliphatic and aromatic ethers (JECFA, 2003b; JECFA, 2005b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
16.088 
1415 
l-Menthylmethylether 
O
4054 
- 
1565-76-0 
Liquid 
C11H22O 
170.30 
Insoluble 
Soluble 
81 (14 hPa) 
- 
IR NMR MS 
99 % 
1.441-1.447 
0.856-0.862 
 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95%  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
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TABLE 2: GENOTOXICITY DATA  
Table 2.1: Genotoxicity Data (in vitro / in vivo) for 30 Aliphatic and Aromatic Ethers (JECFA, 2004b)  
Table 2.1: Summary of Genotoxicity Data for 30 Aliphatic and Aromatic Ethers 
FL-no 
JECFA-no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
In vitro 
03.001 
1234 
1,8-Cineole 
O
 
Reverse mutation S. typhimurium TA102, TA100, 
TA98, TA97 
250–2500 µg/plate Negativea (Gomes-Carneiro et al., 1998) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3.3–3333 µg/plate Negativea,b (Haworth et al., 1983) 
Sister chromatid 
exchange 
Chinese hamster ovary cells 50–500 µg/mlc 
600–800 µg/ml 
Positived 
Negativee 
(Galloway et al., 1987a) 
Sister chromatid 
exchange 
Chinese hamster ovary cells CHO 
K-1 
10, 33.3 and 100 µmol/l (1.5, 
5.1 and 15.4 µg/ml)f 
Negatived (Sasaki et al., 1989) 
Chromosomal 
aberrations 
Chinese hamster ovary cells 479–663 µg/ml 630–810 
µg/ml 
Negatived  
Negativee 
(Galloway et al., 1987a) 
DNA repair Bacillus subtilis H17 (rec+) and 
M45 (rec-) 
18 µg/disk Negativeg (Oda et al., 1979) 
DNA repair Bacillus subtilis H17 (rec+) and 
M45 (rec-) 
< 20 µl/disk (20000 µg 
/disk)h 
Negativeg (Yoo, 1986) 
03.004 
1256 
Dibenzyl ether 
O
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
< 3.6 mg/plate Negativea (Wild et al., 1983) 
04.015 
1243 
1-Methoxy-4-
methylbenzene 
O
 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3 µmol/plate (367µg/ plate)j Negativea (Florin et al., 1980) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
50000 µg/plate Negativea (Heck et al., 1989) 
Unscheduled DNA 
synthesis 
Rat hepatocytes 188 µg/ml Positive (Heck et al., 1989) 
04.016 
1249 
1,3-Dimethoxybenzene 
O
O Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
< 3.6 mg/plate Negativea (Wild et al., 1983) 
04.032 
1241 
Anisole 
O
 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3 µmol/plate (324 µg /plate)i Negativea (Florin et al., 1980) 
Sister chromatid 
exchange 
Human lymphocytes 0–2.0 mol/l (0– 216 µg/ml)i Negative (Jansson et al., 1988) 
04.033 
1258 
beta-Naphthyl ethyl ether O
 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
< 3.6 mg/plate Negativea (Wild et al., 1983) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3 mmol/plate (517µg/ plate)p Negativea (Florin et al., 1980) 
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Table 2.1: Summary of Genotoxicity Data for 30 Aliphatic and Aromatic Ethers 
FL-no 
JECFA-no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
04.034 
1250 
1,4-Dimethoxybenzene 
OO
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
10–900 µg/plate Negativea,b (Haworth et al., 1983) 
04.035 
1255 
Diphenyl ether 
O  
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3 µmol/plate (511 µg/ plate)l Negativea (Florin et al., 1980) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1532, TA1535, TA1537, 
TA1538, TA2636 
0.1–500 µg/plate Negativea (Pagano et al., 1983) 
Reverse mutation S. typhimurium TA100, TA97, 
TA98, TA102 
< Cytotoxic concentrations (≥ 
10-2 mmol/l or 17 µg/ml)l 
Negativea (Pagano et al., 1988) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3.3–333.3 µg/plate Negativea,b (Pagano et al., 1983) 
Reverse mutation S. typhimurium TA100, TA1538, 
TA98, TA1537, TA1535 
1–10 000 µg/plate Negativea (Clark et al., 1979) 
Reverse mutation S. typhimurium TA1535, TA100, 
TA1538, TA98, TA1537, TA1978 
5 and 10 µl/plate (5000 and 11 
000 µg/plate)m 
Negaitvea (Westinghouse Electric 
Corporation, 1984) 
Mutations Saccharomyces cerevisiae D7 Up to 1 mmol/l (170 µg/ml)l Negativea (Pagano et al., 1983) 
Chromosomal 
aberrations 
Chinese hamster ovary cells 5–5000 µg/ml Negativea (San Sebastian, 1989b) 
Unscheduled DNA 
synthesis 
Rat hepatocytes 0.5–100 µg/ml Negative (Bakke and Mirsalis, 1987) 
Unscheduled DNA 
synthesis 
Rat hepatocytes 0.1–1000 µg/mln Negative (Farr, 1987a) 
04.039 
1244 
1-Methoxy-4-propylbenzene O
 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
≤750 µg/plate Negativea (Wild et al., 1983) 
Unscheduled DNA 
synthesis 
Rat hepatocytes ≥5 x 10-3 mol/l (751µg/ml)k 
and above 
Negative (Howes et al., 1990) 
04.054 
1259 
Isobutyl beta-naphthyl ether 
O
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
≤1 mg/plate Negativea (Wild et al., 1983) 
04.062 
1248 
1,2-Dimethoxybenzene OO Reverse mutation S. typhimurium TA100 0.1, 1, 10, 100 and 1000 µg/ 
plate 
Negative (Rapson et al., 1980) 
04.074 
1257 
2-Methoxynaphthalene O Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
3 µmol/plate (475 µg/ plate)o Negativea (Florin et al., 1980) 
In vivo 
03.004 
1256 
Dibenzyl ether 
O  
Micronucleus 
formation 
Mice 400, 700 or 1000 mg/kgbwt Negativeq (Wild et al., 1983) 
Sex-linked 
recessive lethal 
mutation 
Drosophila melanogaster 10 mmol/l (1983µg/ml)u Negative (Wild et al., 1983) 
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Table 2.1: Summary of Genotoxicity Data for 30 Aliphatic and Aromatic Ethers 
FL-no 
JECFA-no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
04.016 
1249 
1,3-Dimethoxybenzene 
O
O
 
Micronucleus 
formation 
Mice 558, 966, or 1382 mg/kgbw Negativeq (Wild et al., 1983) 
Sex-linked 
recessive lethal 
mutation 
Drosophila melanogaster 25 mmol/l (3454 µg/ml)s Negative (Wild et al., 1983) 
04.033 
1258 
beta-Naphthyl ethyl ether O
 
Micronucleus 
formation 
Mice 344, 603, 861 mg/kgbw Negativeq (Wild et al., 1983) 
Sex-linked 
recessive lethal 
mutation 
Drosophila melanogaster 25 mmol/l (4,306 µg/ml)p Negative (Wild et al., 1983) 
04.039 
1244 
1-Methoxy-4-propylbenzene O
 
Micronucleus 
formation 
Mice 750, 1125, 1500mg/kg Negativeq (Wild et al., 1983) 
Sex-linked 
recessive lethal 
mutation 
Drosophila melanogaster 5 mmol/l (751µg/ml)k Negativer (Wild et al., 1983) 
04.054 
1259 
Isobutyl beta-naphthyl ether 
O
 
Micronucleus 
formation 
Mice 800, 1,400, or 2000 mg/kgbw Negativeq (Wild et al., 1983) 
Sex-linked 
recessive lethal 
mutation 
Drosophila melanogaster 25 mmol/l Negativev (Wild et al., 1983) 
a With or without metabolic activation. 
b Pre-incubation method. 
c Lowest dose to give a significant increase in sister chromatid exchange: Trial I—500 µg/ml, Trial II—200 µg/ml. 
d Without metabolic activation. 
e With metabolic activation. 
f Calculated using relative molecular mass of eucalyptol = 154.25. 
g Foreign language article, data available from English abstract and/or tables. 
h Calculated using density of eucalyptol = 0.921–0.924 (Food Chemical Codex, 1996). 
i Calculated using relative molecular mass of anisole = 108.14. 
j Calculated using relative molecular mass of p-methylanisole = 122.17. 
k Calculated using relative molecular mass of p-propylanisole = 150.22. 
l Calculated using relative molecular mass of diphenyl ether = 170.21. 
m Calculated using density of diphenyl ether = 1.07 (Arctander, 1969). 
n These values are for a mixture containing 73.5% diphenyl ether and 26.5% biphenyl. 
o Calculated using relative molecular mass of _-naphthyl methyl ether = 158.2. 
p Calculated using relative molecular mass of _-naphthyl ethyl ether = 172.23. 
q Administered via intraperitoneal injection. 
r In one of the four tests using I-propylanisole, high frequencies of sex-linked recessive lethal mutation were observed in two broods, which were significantly (p ≤ 0.01) above the control value. However, the authors noted that four doubles 
(two lethal mutations from one male) were observed in the test, and due to the lack of effects seen in the other three tests, the doubles were considered pre-existing and of spontaneous origin (Wild et al., 1983). 
s Calculated using relative molecular mass of m-dimethoxybenzene = 138.17. 
t Administered twice within a 24-hoursperiod. 
u Calculated using relative molecular mass of dibenzyl ether= 198.27. 
v A slight increase “with a borderline significance of p = 0.05” in frequencies of sex-linked recessive lethal mutations was reported in the second brood of three, which was considered of questionable relevance and not a positive result (Wild et 
al., 1983). The “borderline” significance reported (p = 0.05) appears to be due to the abnormally low frequency of sex-linked recessive lethal mutations in the corresponding control brood (control brood II: 34/17734 or 0.19%) when compared 
to the control groups of the other two broods (control brood I: 42/18188 or 0.23 % and control brood III: 50/16980 or 0.29 %). 
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Table 2.2: Genotoxicity Data (in vitro) EFSA / FGE.23Rev2 
Substances listed in brackets are the JECFA evaluated supporting substances in FGE.23Rev2 
Table 2.2: GENOTOXICITY (in vitro) 
Chemical Name [FL-no] Test System Test Object  Concentration Result  Reference  Comments 
(Anisole [04.032]) Ames reverse mutation assay 
(plate incorporation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
3 µmol/plate Negative (+/- S9) (Florin et al., 1980) 2. 
Sister chromatid exchange Human lymphocytes 2 mM Negative (-S9 
only) 
(Jansson et al., 1988) 2. 
(1-Methoxy-4-methylbenzene 
[04.015]) 
Ames reverse mutation assay 
(plate incorporation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
3 µmol/plate Negative (+/- S9) (Florin et al., 1980) Published Non-GLP study. Limited report 
of study details. Validity of the study 
cannot be evaluated. 
Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
50 mg/plate Negative (+/- S9) (Heck et al., 1989) Published non-GLP study. Some important 
details of study design and results are not 
reported. Thus, the validity of the study 
cannot be evaluated. 
Unscheduled DNA synthesis Rat hepatocytes 188 µg/ml Positive (Heck et al., 1989) Published non-GLP study. No information 
concerning the number of concentrations 
tested. Due to the lack of some important 
details of study design and results the 
validity of the study cannot be evaluated. 
(1,2-Dimethoxybenzene [04.062]) Ames reverse mutation assay S. typhimurium  
TA100 
1000 µg/plate Negative (Rapson et al., 1980) 2. 
(1,3-Dimethoxybenzen [04.016]) Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
3.6 mg/plate Negative (+/- S9) (Wild et al., 1983) 2. 
(1,4-Dimethoxybenzene [04.034]) Ames reverse mutation assay 
(preincubation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
900 µg/plate Negative (+/- S9) (Haworth et al., 1983) 2. 
Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
5000 ng/plate Negative (+/- S9) (CIT) 2. 
1,2,3-Trimethoxybenzene [04.084] Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537 
3 µmol/plate Negative (+/- S9) (Florin et al., 1980) Tested quantitatively with TA100. 
Published non-GLP study. Limited report 
of study details. No results reported. 
Validity of the study cannot be evaluated. 
SOS Chromotest E. coli PQ37 NR Negative (Ohshima et al., 1989) Study assessing the SOS-inducing potency 
of a range of phenols after nitrosation in 
vitro in the absence of metabolic activation. 
The result for 1,2,3-trimethoxybenzene was 
negative. 
(1,8-Cineole [03.001]) Ames reverse mutation assay S. typhimurium TA97; TA98; TA100; 
TA102 
2500 µg/plate Negative (+/- S9) (Gomes-Carneiro et al., 
1998) 
Published non-GLP study. Fairly detailed 
description of study details and results, 
generally follows OECD guidelines. Study 
considered valid. 
Ames reverse mutation assay 
(preincubation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
3333 µg/plate Negative (+/- S9) (Haworth et al., 1983) Published summary report including 
detailed results from studies on 250 
compounds tested in various laboratories 
within the NTP to a large extent in 
accordance with OECD guideline 471. 
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Table 2.2: GENOTOXICITY (in vitro) 
Chemical Name [FL-no] Test System Test Object  Concentration Result  Reference  Comments 
(1,8-Cineole [03.001]) cont. Sister chromatid exchange Chinese hamster ovary cells 500 µg/ml
800 µg/ml 
Positive (-S9) 
Negative (+S9) 
(Galloway et al., 1987a) Lowest dose to give a significant increase 
in SCE: Trial I – 500 µg/ml; Trial II – 200 
µg/ml. Published non-GLP study. Doses 
were selected based on preliminary assay. 
Some details of results are not reported. 
Test was positive only without activation 
and at doses that induced cell cycle delay. 
 Sister chromatid exchange Chinese hamster ovary CHO K-1 cells 100 µM Negative (-S9 
only) 
(Sasaki et al., 1989) Published non-GLP study of limited 
quality. Study designed to investigate the 
influence on spontaneous as well as on 
mitomycin-induced SCEs. 
Chromosomal aberration 
assay 
Chinese hamster ovary cells 663 µg/ml 
810 µg/ml 
Negative (+/- S9) (Galloway et al., 1987a) Published non-GLP study. Doses were 
selected based on preliminary assay. 
Although some details of results are not 
reported the study is considered valid. No 
aberration induction was detected even 
after extending the incubation time without 
S9 to 20 hours. 
Rec assay B. subtilis H17 (rec+) and M45 (rec-) 18 µg/disk Negative (Oda et al., 1979) Study published in Japanese without 
English abstract. Data extracted from 
tables. Validity of the study cannot be 
evaluated. The SOS chromotest is not 
considered predictive for genotoxicity. 
Rec assay B. subtilis H17 (rec+) and M45 (rec-) 20 µl/disk  
(20,000µg/disk) 
Negative (Yoo, 1986) Study published in Japanese with English 
abstract. Data extracted from tables. 
Validity of the study cannot be evaluated. 
The SOS chromotest is not considered 
predictive for genotoxicity. 
(1-Methoxy-4-propylbenzene 
04.039]) 
Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
750 µg/plate Negative (+/- S9) (Wild et al., 1983) 2. 
Unscheduled DNA synthesis Rat hepatocytes 5x10-3 M Negative (Howes et al., 1990) 2. 
(2-Methoxynaphthalene [04.074]) Ames reverse mutation assay 
(plate incorporation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
3 µmol/plate Negative (+/- S9) (Florin et al., 1980) 2. 
(beta-Naphthyl ethyl ether [04.033]) Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
3.6 mg/plate Negative (+/- S9) (Wild et al., 1983) 2. 
Ames reverse mutation assay 
(plate incorporation method) 
S. typhimurium TA98; TA100; TA1535; 
TA1537 
3 µmol/plate Negative (+/- S9) (Florin et al., 1980) 2. 
(Isobutyl beta-naphthyl ether 
[04.054]) 
Ames reverse mutation assay S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
1 mg/plate Negative (+/- S9) (Wild et al., 1983) 2. 
(2-Phenoxyethyl isobutyrate 
[09.487]) 
Ames reverse mutation assay S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
3600 µg/plate Negative (+/- S9) (Wild et al., 1983) 3. 
(Phenoxyacetic acid [08.049]) Mutagenicity assay S. cerevisiae D7tsl 16 mM Negative (- S9) (Venkov et al., 2000) 
 
3. 
(Alpha-terpineol [02.014]) Ames test S. typhimurium TA98; TA100; TA1535; 
TA1537; TA1538 
10000 µg/plate Negative (Heck et al., 1989) 4. 
Ames test S. typhimurium TA97a; TA98; TA100; 
TA102 
2500 µg/plate Negative1 (Gomes-Carneiro et al., 
1998) 
4. 
(Alpha-terpineol [02.014]) cont. Ames test S. typhimurium TA98; TA100; TA1535; 1000 µg/plate Negative (+/- S9) (National Cancer 4. 
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Table 2.2: GENOTOXICITY (in vitro) 
Chemical Name [FL-no] Test System Test Object  Concentration Result  Reference  Comments 
TA1537; TA1538 Institute, 1983) 
Spot test S. typhimurium TA98, TA100, TA1535, 
TA1537 
3 µg/plate (463 µg/plate) Negative (+/- S9) (Florin et al., 1980) 4. 
Mammalian cell mutation Mouse Lymphoma L5178Y TK +/- 0.5 µl/ml (467µg/ml) 
0.75µl/ml (700 µg/ml) 
Negative (- S9) 
Negative (+S9) 
(Kirby et al., 1984) 4. 
Mammalian cell mutation Mouse Lymphoma L5178Y TK +/- 300 nl/ml (280 µg/ml)  
250 nl/ml (233 µg/ml) 
Negative (+/- S9) (Heck et al., 1989) 4. 
Rec assay S. cerevisiae NR Negative (Oda et al., 1979) 4. 
(Terpineol acetate [09.830]) Rec assay B. subtilis H17; M45 19 µg Negative (Oda et al., 1979) 4. 
Vanillin 3-(l-menthoxy)propane-1,2-
diol acetal [02.248] 
Ames test S. typhimurium TA98; TA100; TA1535; 
TA1537 
Up to 5000 µg/plate Negative (+/- S9) (Kajiura, 1996b) The study is not completely in accordance 
with OECD guidelines (471): no 
confirmation of negative findings in an 
independent experiment and only two 
plates pr concentration. 
Ames test E. coli WP2 uvrA Up to 5000 µg/plate Negative (+/- S9) (Kajiura, 1996b) The study is not completely in accordance 
with OECD guidelines (471): no 
confirmation of negative findings in an 
independent experiment and only two 
plates pr concentration. 
1 A slight but dose-related response was noted with TA102 with and without the use of metabolic activation.  
2 Summarised by JECFA 61st meeting (JECFA, 2004b). 
3 Summarised by JECFA 59th meeting (JECFA, 2003a). 
4 Summarised by JECFA 51st meeting (JECFA, 1999a . 
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Table 2.3: Genotoxicity Data (in vivo) for EFSA / FGE.23Rev2 
Substances listed in brackets are the JECFA evaluated supporting substances in FGE.23Rev2 
Table 2.3: GENOTOXICITY (in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Result  Reference  Comment
s 
(1,3-Dimethoxybenzene [04.016]) In vivo Micronucleus test Mouse Intraperitoneal injection 1382 mg/kg bw Negative (Wild et al., 1983) 1 
In vivo Sex- linked recessive lethal 
mutation assay 
D. melanogaster  25 mM Negative (Wild et al., 1983) 1 
(1,4-Dimethoxybenzene [04.034]) In vivo Micronucleus test Mouse Oral gavage 2000 mg/kg bw Negative (Hoechst, 1996) 1 
(1-Methoxy-4-propylbenzene [04.039])  In vivo Micronucleus test Mouse Intraperitoneal injection 1500 mg/kg Negative (Wild et al., 1983) 1 
In vivo Sex- linked recessive lethal 
mutation assay 
D. melanogaster (751 µg/ml) 5 mM Negative (+/- S9) (Wild et al., 1983) 1 
(beta-Naphthyl ethyl ether [04.033]) In vivo Micronucleus test Mouse Intraperitoneal injection 861 mg/kg bw Negative (Wild et al., 1983) 1 
In vivo Sex- linked recessive lethal 
mutation assay 
D. melanogaster  25 mM Negative (Wild et al., 1983) 1 
(Isobutyl beta-naphthyl ether [04.054]) In vivo Micronucleus test Mouse Intraperitoneal injection 2000 mg/kg bw Negative (Wild et al., 1983) 1 
In vivo Sex- linked recessive lethal 
mutation assay 
D. melanogaster  25 mM  Negative (Wild et al., 1983) 1 
(2-Phenoxyethyl isobutyrate [09.487]) In vivo Micronucleus formation 
assay 
Mouse bone marrow 
cells 
IP injection 1875 mg/kg/bw Negative (Wild et al., 1983) 2 
In vivo Sex-linked recessive 
mutation 
D. melanogaster  10 mM  Negative (Wild et al., 1983) 2 
1 Summarised by JECFA 61st meeting (JECFA, 2004b) 
2 Summarised by JECFA 59th meeting (JECFA, 2003a) 
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TABLE 3.1: SUMMARY OF SAFETY EVALUATION OF ALIPHATIC AND AROMATIC ETHERS (JECFA, 2004B; JECFA, 2006A) 
Table 3.1: Summary of Safety Evaluation of Aliphatic and Aromatic Ethers (JECFA, 2004b; JECFA, 2006d) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, genotoxicity) 
EFSA conclusion on the 
material of commerce 
04.014 
1242 
1-Methoxy-2-methylbenzene O
 
2.4 
0.06 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.015 
1243 
1-Methoxy-4-methylbenzene O
 
0.49 
15 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.016 
1249 
1,3-Dimethoxybenzene OO
 
4.6 
2 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.032 
1241 
Anisole O
 
0.024 
0.01 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.034 
1250 
1,4-Dimethoxybenzene O
O  
15 
7 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.038 
1247 
Carvacryl ethyl ether 
O
0.085 
0.02 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.043 
1246 
1-Isopropyl-2-methoxy-4-
methylbenzene 
O
1.7 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.062 
1248 
1,2-Dimethoxybenzene O
O
1.6 
20 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
04.063 
1245 
1,3-Dimethyl-4-methoxybenzene 
O
0.12 
0.2 
Class I 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
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Table 3.1: Summary of Safety Evaluation of Aliphatic and Aromatic Ethers (JECFA, 2004b; JECFA, 2006d) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, genotoxicity) 
EFSA conclusion on the 
material of commerce 
03.003 
1252 
Benzyl ethyl ether O
 
0.0024 
2 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
03.005 
1231 
2-Butyl ethyl ether O
 
6.9 
0.3 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
03.006 
1254 
2-Methoxyethyl benzene O
 
26 
0.01 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
03.007 
1233 
1,4-Cineole 
O
3.9 
146 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
 
03.010 
1253 
Benzyl butyl ether O
 
0.012 
0.02 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
According to JECFA: Min. assay 
value is "92.6" and secondary 
components "Benzyl alcohol". 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
03.019 
1232 
Prenyl ethyl ether O
 
0.73 
2 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
13.037 
1237 
2-(2-Methylprop-1-enyl)-4-
methyltetrahydropyran 
O
 
3.8 
0.2 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
Composition of stereoisomeric 
mixture to be specified. 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
13.088 
1235 
3,6-Dihydro-4-methyl-2-(2-
methylprop-1-en-1-yl)-2H-pyran 
O 0.85 
0.7 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
13.094 
1236 
2,6,6-Trimethyl-2-
vinyltetrahydropyran 
O
 
0.012 
8 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
13.098 
1238 
Theaspirane 
O
1.7 
0.1 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach.  
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Table 3.1: Summary of Safety Evaluation of Aliphatic and Aromatic Ethers (JECFA, 2004b; JECFA, 2006d) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, genotoxicity) 
EFSA conclusion on the 
material of commerce 
13.165 
1239 
6,7,8,8a-Tetrahydro-2,5,5,8a-
tetramethyl-5H-1-benzopyran 
O 0.14 
2 
Class II 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
03.001 
1234 
1,8-Cineole 
O
1200 
1954 
Class II 
A3: Intake above threshold, 
A4: Not endogenous, A5: 
Adequate NOAEL exists 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.033 
1258 
beta-Naphthyl ethyl ether O 43 
4 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
04.035 
1255 
Diphenyl ether 
O  
12 
5 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.040 
1251 
1,2-Dimethoxy-4-vinylbenzene O
O
0.012 
0.01 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
04.054 
1259 
Isobutyl beta-naphthyl ether 
O
1.2 
2 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
04.074 
1257 
2-Methoxynaphthalene O 3.5 
0.01 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at the 
estimated level of intake based 
on the MSDI approach 
13.072 
1240 
1,5,5,9-Tetramethyl-13-oxatricyclo 
[8.3.0.0.(4.9)]tridecane O
 
1.2 
0.1 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
Composition of stereoisomeric 
mixture to be specified 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
16.088 
1415 
l-Menthylmethylether 
O
1.2 
53 
Class III 
A3: Intake below threshold 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
CASrn refers to the (1S,2R,4R) 
isomer. The name specify the 
isomer (1S,2R,4R). 
No safety concern at the 
estimated level of intake based 
on the MSDI approach. 
03.004 
1256 
Dibenzyl ether 
O
 
0.49 
241 
Class III 
A3: Intake above threshold, 
A4: Not endogenous, A5: 
Adequate NOAEL exists 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
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Table 3.1: Summary of Safety Evaluation of Aliphatic and Aromatic Ethers (JECFA, 2004b; JECFA, 2006d) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(Procedure steps, intake 
estimates, NOAEL, genotoxicity) 
EFSA conclusion on the 
material of commerce 
04.039 
1244 
1-Methoxy-4-propylbenzene O
 
20 
114 
Class III 
A3: Intake above threshold, 
A4: Not endogenous, A5: 
Adequate NOAEL exists 
4) No safety concern at the estimated 
level of intake based on the MSDI 
approach 
No safety concern at estimated 
levels of intake as flavouring 
substances based on the MSDI 
approach. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (EFSA / FGE.23Rev2) 
Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (EFSA, 2010ac) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound [ 4) or 5] 
Outcome on the material of 
commerce [6), 7), or 8)] 
04.059 
 
Carvacryl methyl ether 
O
1.2 
 
Class I 
A3: Intake below threshold 
4) 6) 
04.084 
 
1,2,3-Trimethoxybenzene 
O O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6) 
03.008 
 
2-Acetoxy-1,8-cineole 
O
O
O
0.037 
 
Class II 
A3: Intake below threshold 
4) 6) 
03.011 
 
Benzyl methyl ether O 1.9 
 
Class II 
A3: Intake below threshold 
4) 6) 
03.012 
 
Benzyl octyl ether O 0.24 
 
Class II 
A3: Intake below threshold 
4) 6) 
03.015 
 
Ethyl geranyl ether 
O
0.012 
 
Class II 
A3: Intake below threshold 
4) 6) 
03.016 
 
Hexyl methyl ether  
O
0.012 
 
Class II 
A3: Intake below threshold 
4) 6) 
04.079 
 
Methyl-4-methoxybenzyl ether O
O
0.61 
 
Class II 
A3: Intake below threshold 
4) 6) 
02.247 
1853 
l-Menthoxyethanol 
O
OH
15 
 
Class III 
A3: Intake below threshold 
4) 6) 
02.248 
1879 
Vanillin 3-(l-menthoxy)propane-1,2-diol 
acetal 
O
O
O
OHO
0.61 
 
Class III 
A3: Intake below threshold 
4) 6) 
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (EFSA, 2010ac) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound [ 4) or 5] 
Outcome on the material of 
commerce [6), 7), or 8)] 
03.020 
 
alpha-Terpinyl methyl ether 
O
4.1 
 
Class III 
A3: Intake below threshold 
4) 6) 
03.022 
1802 
1-Methoxy-1-decene O 6.1 
 
Class III 
A3: Intake below threshold 
4) 7) 
03.024 
 
Digeranyl ether 
O
49 
 
Class II 
A3: Intake below threshold 
4) 6) 
04.067 
 
1-Ethoxy-2-methoxybenzene O
O
0.12 
 
Class III 
A3: Intake below threshold 
4) 6) 
04.068 
 
1-Ethoxy-4-methoxybenzene 
O
O 0.67 
 
Class III 
A3: Intake below threshold 
4) 6) 
04.069 
 
1-Ethyl-4-methoxybenzene O 0.073 
 
Class III 
A3: Intake below threshold 
4) 6) 
04.075 
 
1-Methoxynaphthalene 
O
0.061 
 
Class III 
A3: Intake below threshold 
4) 6) 
08.127 
 
2-(4-Methoxyphenoxy)propionic acid 
O
O
OH
O 0.011 
 
Class III 
A3: Intake below threshold 
4) 6) 
09.687 
 
2-Phenoxyethyl butyrate 
O
O
O 0.085 
 
Class III 
A3: Intake below threshold 
4) 6) 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365) = µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ABBREVIATIONS 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good laboratory practise 
ID  Identity 
Ip  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
No  Number 
NOAEL  No observed adverse effect level 
NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
PCE  Polychromatic erythrocyte 
SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
WHO  World Health Organisation 
